Stock Ratings / Technology / CLBT / forecast

SPSC (74) INTA (49) TDC (57) VIA (39) ⌘ Pro Terminal →

Cellebrite DI Ltd. (CLBT) 12-Month Stock Forecast & Price Target Cone

$12.28 +3.02% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $12.38

Cellebrite DI Ltd. (CLBT) earns a Roarable Rating of B (Buy) with 73/100 RQD Confidence. High-quality cash engine (84% profit margin, 15% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 73/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.1% avg 90D alpha vs SPY • 69.0% hit rate) →

ROARABLE B • BUY Cap $3.09B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $12.38 (+0.78%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 33.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 73/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.1% avg 90D alpha vs SPY • 69.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+6.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CLBT)Realized 20D OHLCV Swing Band: ±7.5%

Deterministic 5-Pillar Attribution (73/100 Composite)

🔍 WHY CLBT SCORES 73/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (25% of score)

Altman Z-Score 4.95 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 33.7% FCF Margin ($160.3M FCF) & 84.2% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$11.26-2% Next Q

Q2 (-2Q)

Grade B-$11.03+9.7% Next Q

Q3 (-1Q)

Grade B$12.10+1.5% Next Q

Current

Grade B$12.28+7.1% Hist 90D α

Trajectory: C+ (65) → B (73)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the CLBT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 73/100 (B) score, CLBT faces multiple-compression risk if 39.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 39x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 81.7% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($11.50) or 200D SMA ($13.40) invalidates the momentum regime and cuts Target Base ($13.11) toward Bear Floor ($10.07).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CLBT• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CLBT Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 73%NO 27%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your CLBT Position Size: $10,000

Shares at $12.28: 814.3 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $10.07

$8,200

$-1,800 (-18.0%)

12M Consensus BaseTarget $13.11

$10,676

+$676 (+6.8%)

12M Bull Case BreakoutTarget $20.98

$17,085

+$7,085 (+70.8%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (34 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 23● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	OUTPERFORM	$14	74%	A
Goldman SachsSector Coverage Lead	BUY	$20	69%	B
JP MorganUS Large-Cap Research	HOLD	$12	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (CLBT Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CLBT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -5.54%📐 WEDGE COMPRESSION COIL

2026-10-30O $12.24H $12.28L $12.01C $12.28VOL 1.74M

RES: $15.02SUP: $10.96SMA50: $11.50SMA200: $13.40

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CLBT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CLBT Butterfly Map → + Track CLBT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

30.0%/yr Implied 5Y Growth

vs. +18.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CLBT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CLBT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CLBT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CLBT)

Technology Rank #65 of 714 ⚔️ SPSC vs CLBT Full Matrix →

1. Head-to-Head Technology Peer Comparison (CLBT vs. SPSC, INTA, TDC, VIA)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Cellebrite DI Ltd. (CLBT) ranks #65 by composite RQD confidence (73/100, grade B) and #252 by equity capitalization ($3.09B). Within this direct 5-issuer industry benchmark cohort, TDC leads on earnings valuation at 24.8x trailing P/E, while TDC leads on capital efficiency and profitability with 85.0% ROIC and 59.4% gross margin. SPSC currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with CLBT at 73/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CLBT ACTIVE Cellebrite DI Ltd.	B	73/100	39.4x	84.2%	14.6%	+3.02%	$3.09B	Benchmark Subject
SPSC SPS Commerce Inc.	B	74/100	33.1x	69.2%	11.4%	+0.22%	$3.09B	/spsc-vs-clbt →
INTA Intapp Inc.	D	49/100	—	74.0%	-9.9%	-3.07%	$3.00B	/inta-vs-clbt →
TDC Teradata Corporation	D+	57/100	24.8x	59.4%	85.0%	+0.76%	$3.22B	/tdc-vs-clbt →
VIA Via Transportation Inc. (Class A)	D-	39/100	—	39.6%	-23.6%	-1.04%	$2.94B	/via-vs-clbt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001854587

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cellebrite DI Ltd. (CLBT) reported GAAP revenue of $475.7M (+18.6% vs. FY2024 revenue of $401.2M , and +46.3% cumulative change since FY2023) , GAAP net income of $78.3M, operating cash flow of $173.5M, and free cash flow of $160.3M (+29.7% YoY). On the balance sheet, CLBT closed FY2025 with $938.9M in total assets against $0 in total debt (Altman Z-Score: 4.95, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$475.7M	$78.3M	$173.5M	$160.3M	$938.9M	—
FY2024 (FY)	2024-12-31	$401.2M	-$283.0M	$132.2M	$123.6M	$690.6M	—
FY2023 (FY)	2023-12-31	$325.1M	-$81.1M	$102.1M	$102.1M	—	—

3. CLBT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CLBT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Cellebrite DI Ltd. (NASDAQ: CLBT) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $12.28 (+3.02% 1D, market cap $3.09B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 15/20. Across 714 tracked Technology issuers, CLBT ranks #65 in composite RQD confidence.

How does CLBT compare to SPSC and INTA in the Technology sector?

Within the Technology sector (Computer Software: Prepackaged Software), CLBT carries a Roarable B (73/100 RQD), trailing P/E of 39.4x, gross margin of 84.2%, and ROIC of 14.6%. By comparison, SPSC (SPS Commerce Inc.) holds a B grade (74/100 RQD, P/E 33.1x, ROIC 11.4%, cap $3.09B) and INTA (Intapp Inc.) posts a D grade (49/100 RQD, P/E N/A, ROIC -9.9%, cap $3.00B). Among the 5-stock peer group, TDC leads on earnings multiple (24.8x) while TDC leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CLBT?

Per CLBT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001854587), Cellebrite DI Ltd. generated $475.7M in revenue (+18.6% YoY), $78.3M in net income, and $160.3M in free cash flow against $938.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (84% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Priced at 39x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CLBT trading relative to its 50-day, 200-day, and 52-week technical levels?

CLBT last traded at $12.28 (+3.02% on volume of 2,115,840 shares), positioning the stock +6.78% above its 50-day simple moving average ($11.50) and -8.36% below its 200-day simple moving average ($13.40). Across its 52-week range of $9.58 to $19.98, CLBT sits at the 26.0% percentile with a 14-day RSI of 58.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.5% ($11.36 to $13.20).

CLBT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is CLBT's 12-month stock price target?

Cellebrite DI Ltd. (CLBT) carries a 12-month consensus base price target of $13.11 (+6.8% from $12.28), with a bull-case target of $20.98 and a bear-case floor of $10.07.

Is CLBT stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates CLBT B (Buy — BUY) with an RQD Confidence score of 73/100.

Direct Sub-Reports: CLBT RQD Cockpit CLBT 12M Forecast CLBT Earnings & Move CLBT Dividends & DRIP CLBT Insiders & 13F CLBT Whale Options CLBT Profit Sankey CLBT News & Why